Osman E, Khalil N, Magdy A, El-Dash Y
RSC Med Chem. 2024; 15(8):2692-2708.
PMID: 39149111
PMC: 11324043.
DOI: 10.1039/d4md00135d.
Abd-Rabo Z, Serry A, George R
Future Med Chem. 2024; 16(16):1685-1703.
PMID: 39105606
PMC: 11370926.
DOI: 10.1080/17568919.2024.2379234.
Boukharsa Y, Karrouchi K, Attjioui H, Ansar M, Ansar M
Mini Rev Med Chem. 2024; 25(1):3-26.
PMID: 38859779
DOI: 10.2174/0113895575287746240528072330.
Alsaiari A, Almehmadi M, Asif M
Med Chem. 2023; 20(3):245-267.
PMID: 37711126
DOI: 10.2174/1573406419666230913102835.
Alagoz M, Ozdemir Z, Uysal M, Carradori S, Gallorini M, Ricci A
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33668893
PMC: 7996573.
DOI: 10.3390/ph14030183.
Synthesis and biological evaluation of new 3(2)-pyridazinone derivatives as non-toxic anti-proliferative compounds against human colon carcinoma HCT116 cells.
Ozdemir Z, Utku S, Mathew B, Carradori S, Orlando G, Di Simone S
J Enzyme Inhib Med Chem. 2020; 35(1):1100-1109.
PMID: 32321320
PMC: 7191905.
DOI: 10.1080/14756366.2020.1755670.
Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Ozdemir Z, Alagoz M, Uslu H, Karakurt A, Erikci A, Ucar G
Pharmacol Rep. 2020; 72(3):692-704.
PMID: 32144745
DOI: 10.1007/s43440-020-00070-w.
Experimental and Computational Approaches for Solubility Measurement of Pyridazinone Derivative in Binary (DMSO + Water) Systems.
Shakeel F, Alshehri S, Imran M, Haq N, Alanazi A, Anwer M
Molecules. 2020; 25(1).
PMID: 31906205
PMC: 6983045.
DOI: 10.3390/molecules25010171.
Synthesis, Characterization and Solubility Determination of 6-Phenyl-pyridazin-3(2)-one in Different Pharmaceutical Solvents.
Shakeel F, Imran M, Haq N, Alshehri S, Anwer M
Molecules. 2019; 24(18).
PMID: 31546846
PMC: 6767300.
DOI: 10.3390/molecules24183404.
Synthesis and In Vitro Biological Evaluation of 1,3,4-Oxadiazol-2(3H)-one and Tetrahydropyridazine-3,6-dione Derivatives of Fatty Acids.
Hassan M, Rauf A, Sherwani A, Owais M
Sci Pharm. 2016; 83(3):429-43.
PMID: 26839828
PMC: 4727767.
DOI: 10.3797/scipharm.1503-10.
Crystal structure of 4-chloro-2-[(5-eth-oxy-1,3,4-thia-diazol-2-yl)meth-yl]-5-(piperidin-1-yl)pyridazin-3(2H)-one.
Li H, Ren X, Li Y, Zhao L
Acta Crystallogr Sect E Struct Rep Online. 2014; 70(Pt 10):o1113.
PMID: 25484702
PMC: 4257213.
DOI: 10.1107/S1600536814020662.
Mannich bases in medicinal chemistry and drug design.
Roman G
Eur J Med Chem. 2014; 89:743-816.
PMID: 25462280
PMC: 7115492.
DOI: 10.1016/j.ejmech.2014.10.076.
Synthesis and antihypertensive screening of new derivatives of quinazolines linked with isoxazole.
Rahman M, Rathore A, Siddiqui A, Parveen G, Shahar Yar M
Biomed Res Int. 2014; 2014:739056.
PMID: 25013797
PMC: 4075089.
DOI: 10.1155/2014/739056.
4-[(tert-Butyl-diphenyl-sil-yloxy)meth-yl]pyridazin-3(2H)-one.
Costas-Lago M, Costas T, Vila N, Besada P
Acta Crystallogr Sect E Struct Rep Online. 2014; 69(Pt 12):o1859-60.
PMID: 24860296
PMC: 4004440.
DOI: 10.1107/S1600536813032212.
5-[(tert-Butyl-diphenyl-sil-yloxy)meth-yl]pyridazin-3(2H)-one.
Costas-Lago M, Costas T, Vila N, Teran C
Acta Crystallogr Sect E Struct Rep Online. 2014; 69(Pt 12):o1826-7.
PMID: 24454251
PMC: 3885075.
DOI: 10.1107/S160053681303167X.